First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace 

First CE Mark for Patient Kits as Medical Devices Obtained by MedTrace MedTrace recently gained its first CE mark for two of its medical devices less than 12 months after submitting the technical file. Obtaining the European CE mark demonstrates the company’s commitment and ability to successfully and in a short time bring a product […]

Shrinking the Manufacturing Footprint with PET Point-of-Care

Shrinking the Manufacturing Footprint with PET Point-of-Care “Today, most PET radiopharmaceuticals are produced at centralized locations and distributed. However, there are logistical limitations to this model and that is why it becomes increasingly interesting, and perhaps important, to consider point-of-care manufacturing.”  – Jared Driskill, Senior Medical Advisor at MedTrace, in the January 2024 edition of […]

The First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published

The First Scientific Article Based on a MedTrace-Sponsored Study Has Been Published MedTrace is proud to see the methodology paper “Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW” published in Journal of Nuclear Cardiology (2024) vol. 31. The article is authored, […]

MedTrace Is Proud to Sponsor the Women in Nuclear Cardiology Event at ASNC2023

MedTrace is proud to sponsor The Women in Nuclear Cardiology Event at ASNC2023 MedTrace is showcasing its technology and Phase 3 Clinical Trial at ASNC2023, The American Society of Nuclear Cardiology’s annual conference, taking place in Toronto, Ontario, Canada from September 29 through October 1.   This year, MedTrace is also sponsoring the Women in Nuclear Cardiology […]

MedTrace Receives an 18 Million Euro Investment for Completion of Its Phase 3 Trial

MedTrace Receives an 18 Million Euro Investment for Completion of its Phase 3 Trial The Danish pharmaceutical and medical device company MedTrace has just closed an investment round of 18.2 million euros, overperforming its target of raising 15 million. In a challenging capital market, the investors have reaffirmed their confidence in MedTrace’s goal of making […]